Weemaes, C.

patient syndrome children infection mutation immunodeficiency study icf syndrome feature therapy indinavir level month icf 2 patients retardation deficiency disease count dnmt 3b growth syndromic genet adherence center defect anomaly 6 months zbtb 24 treatment diagnosis pediatr chromosome system figure nijmegen figure 1 motor development delay dnmt 3b mutation range immunodeficiency virus infection disorder response virus department dysplasia ectodermal value baseline nijmegen breakage syndrome plasma analysis syndromic immunodeficiencies hyper-ige syndrome ataxia pediatrics problem adult development expression identi result zidovudine syndromic pid american journal deletion protein hypoplasia identi fied postnatal growth retardation genetic immunol combination inhibitor netherland hyper-ige telangiectasia domain ii .1 bloom immunodeficiencie